Poncet's disease—a novel cause of non-compliance with anti-tuberculous drugs  by Simcock, D.E et al.
CASE REPORT
Poncet’s diseaseFa novel cause of non-compliance
with anti-tuberculous drugs
D.E. Simcock*, D. Mukherjee, N.S.T. Gendi
Department of Respiratory Medicine, Basildon University Hospital, Nethermayne, Basildon, Essex,
SS16 5N1, UK
Introduction
We present a patient with isoniazid resistant
pulmonary tuberculosis (Tb) associated with large
joint polyarthropathy. A diagnosis of Poncet’s
disease (PD) was made. This case highlights the
problems of non-compliance with drug therapy,
directly observed therapy (DOT) and difficulty in
diagnosing PD. The mechanisms for PD are dis-
cussed and the links between mycobacterial infec-
tion and rheumatoid arthritis (Rh.A) are reviewed.
Case report
A 42-year old married man presented with a 6-
month history of cough, sputum, night sweats,
dyspnoea and weight loss. He moved to England
from Tanzania in 1974 and had subsequently not
left the country. He was a heavy consumer of
alcohol (20 units/day), moderate smoker, and had
intermittently been sleeping rough since selling his
house to buy alcohol. A BCG vaccination was given
at birth and he denied any Tb contacts, drug abuse
or high-risk sexual behaviour. The only previous
medical history of note was anaemia secondary to
haemorrhoids.
Clinical examination revealed a temperature of
37.21C, SaO2 of 92% on air, respiratory rate of
24min1, heart rate 128min1 sinus rhythm, BP
140/64mmHg and course inspiratory crackles in the
left upper zone anteriorly were heard on ausculta-
tion of the chest. The examination was otherwise
unrevealing. Initial results were as follows; Na
132mmol/l, K 4.2mmol/l, U 3.4mmol/l, Cr
65 mmol/l, Alb 24 g/l, total protein 50 g/l, Alp
257 IU/l, Alt 62 IU/l, Hb 7.7 g/dl, WCC 8.1 109/l,
Plt 536 109/l, CRP 196mg/l. Blood clotting was
within normal limits. Urinalysis was normal and
urine culture was sterile after incubation. Sputum
analysis demonstrated acid and alcohol-fast bacilli
on Zeihl–Neilsen staining. Chest X-ray showed
bilateral mid-zone shadowing with cavitation
(Fig. 1).
The patient was isolated and treated for pul-
monary Tb with rifater and ethambutol. One
week into his admission, he developed a painful,
swollen left knee. Plain X-rays and MRI examination
of the joint were normal. Joint aspiration revealed
a lymphocytosis only. Synovial fluid cultures
were negative. The knee pain settled with
simple analgesics. Several days later he developed
bilateral ankle discomfort, stiffness, swelling,
and lumbar back pain. Again plain X-rays and
a lumbar spine MRI scan were normal. Serum
urate was 476 mmol/l (o450 mmol/l), ds DNA,
ANCA, HIV, HCV, HBV serology, were negative
and rheumatoid factor was elevated at 204 IU/ml
(0–40 IU/ml). The arthropathy settled with analge-
sia and physiotherapy. At 2 weeks, sputum culture
grew isoniazid resistant Mycobacterium tuberculo-
sis. The organism was sensitive to ciprofloxacin,
which was added in the place of isoniazid. He
was discharged 25 days after admission, on rifam-
picin, pyrazinamide, ethambutol and ciprofloxacin.
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At 2 months he claimed to be compliant with
his treatment and this was supported by urine
discoloration. The ciprofloxacin and pyrazinamide
were discontinued. A month later he complained
of difficulty in walking due to bilateral ankle pain
and swelling. He also reported a painful right
knee, right shoulder pain and bilateral wrist
stiffness. He had stopped taking his anti-Tb
drugs since he attributed his joint symptoms to
these. On clinic review, his sputum was found to be
positive for isoniazid resistant Tb (fully sensitive to
both rifampicin and ethambutol).The patient
agreed to DOT with rifampicin and ethambutol,
where he is now supervised thrice-weekly on the
chest ward.
In the rheumatology clinic, the affected joints
were repeatedly X-rayed and aspirated. The radio-
graphic appearances were normal and aspirate
analysis revealed only leucocytosis. A synovial
biopsy of the left knee demonstrated a sterile
inflammatory infiltrate of lymphocytes with occa-
sional plasma cells and neutrophills. No granulo-
mata or organisms were seen or cultured. Both of
the knee joints, right shoulder and right ankle were
injected with steroids. Over the course of the next
few months, his joint symptoms resolved and his
sputum remained negative for Tb. He continues to
have DOT.
Discussion
The musculoskeletal manifestations of Tb are seen
in 2% of cases. Tb arthritis is the commonest form
and is usually a large joint monoarthropathy where
mycobacteria are isolated from the affected joint.
Pott’s disease is thoracic spine involvement asso-
ciated with a perispinous abscess. A very rare form
of arthropathy in Tb infection is Poncet’s disease. In
1892, Grocco suggested that patients with Tb might
present with arthritis unassociated with tubercles
or abscesses.1 In 1897, Poncet described a poly-
arthritis in the acute stage of Tb, which resolved
without joint damage.2 In PD, no evidence of
bacteriological involvement of the joint is found
and other causes of polyarthropathy are excluded.
It has rarely been reported in this country, where
its’ existence has seldom been accepted. It is not
included in many rheumatology textbooks.3 One
case series examined 50 patients with acute or
treated Tb. No evidence of arthropathy was found
and reported that the links with arthritis were
fortuitous.4 Some authors argue that whilst organ-
isms cannot be isolated from the affected joints,
mycobacterial degradation products and overt
mycobacterial DNA sequences are present in the
synovium.5 With this in mind, it is reportedly
essential to include mycobacterial PCR analysis of
synovial fluid and synovial biopsies before enter-
taining the diagnosis of PD.6
Contrary to this statement, the finding of
mycobacterial sequences in both inflamed and
normal joints can be attributed to the trafficking
of antigens from BCG vaccination.7
The proposed mechanism to explain the patho-
genesis of PD is that of molecular mimicry. Heat
shock proteins from mycobacteria share amino acid
sequences with cartilage proteoglycans, leading to
a T-cell mediated cross reactivity and host cell
damage. There may also be a genetic predisposi-
tion. Those who are HLA DR3 and/or HLA DR4, show
T-cell hyper responsiveness to mycobacterial anti-
gens.8 This same mechanism is believed to be the
cause of the skin manifestation erythema nodosum.
These two conditions may represent expressions of
a common immunogenic response to tuberculin.
The treatment of PD is the same as for pulmonary
Tb. The polyarthropathy responds rapidly to treat-
ment with only one reported case of recurrence.9 In
the case reported, the initial accumulation of joint
symptoms is explained by non-compliance, and
improved with DOT. Our case demonstrates the
difficulty in diagnosing PD. The rheumatoid factor
was elevated, raising the possibility of Rh.A.
However, a raised rheumatoid factor is almost
universal in Tb. On the basis of his symptoms; early
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Figure 1 Extensive bilateral midzone shaddowing and
cavitation as a result of pulmonary Tb.
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morning stiffness, bilateral joint involvement,
arthritis of 43 joints and rheumatoid factor
positivity, he fulfilled the American rheumatism
society criteria for Rh.A. This is unlikely here since
the arthropathy is improving with regular anti-Tb
drugs, and the synovial biopsy and radiology were
not typical for Rh.A. It has previously been
observed that Rh.A rarely occurs in patients with
Tb.3 Infection with mycobacteria and other bacter-
ia have long been implicated in the aetiopathogen-
esis of Rh.A. Suggested mechanisms involve; direct
joint invasion, molecular mimicry and reactive
phenomena or immune dysfunction leading to
autoimmunity. Advances in molecular techniques
continue to cloud the association, since PCR analysis
identifies mycobacterial antigens in rheumatoid and
normal synovium and can identify multiple matched
sequences between bacterium and host cells.
Mycobacteria certainly lead to altered immune
responses as demonstrated by BCG vaccination
enhancing TH1-cell mediated responses and sup-
pression of TH2-cell activity.10 Rigorous proof
implicating mycobacteria in Rh.A pathogenesis is
lacking and moreover, no effective treatment for
the disease has come from work in this area.11
Conclusion
As the incidence of Tb in developed countries
rises, more reports of PD are likely. Heightened
clinician awareness may lead to more rapid
identification of this complication in the interest
of patient care.
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